Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid lowering and coronary risk

A M Gotto1

  • 1Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Israel Journal of Medical Sciences
|June 1, 1996
PubMed
Summary

Lowering cholesterol, especially low-density lipoprotein cholesterol, helps prevent coronary events. Benefits may stem from improved vascular function and reduced inflammation, not just reduced lesion size.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents.

Revista panamericana de salud publica = Pan American journal of public health·2001
Same author

Therapeutic impact of statin therapy in patients with low HDL cholesterol.

Current atherosclerosis reports·2000
Same author

Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.

The American journal of cardiology·2000
Same author

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.

Journal of the American College of Cardiology·2000
Same author

Risk reduction.

Circulation·2000
Same author

Case 1: a patient with elevated low-density lipoprotein cholesterol.

The American journal of cardiology·2000

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Preventive Cardiology

Background:

  • Clinical trials confirm the importance of lipid lowering for preventing coronary events.
  • Advances in lipid-regulating agents allow for greater cholesterol reduction, particularly low-density lipoprotein (LDL) cholesterol.

Purpose of the Study:

  • To explore the mechanisms by which lipid lowering prevents coronary events.
  • To investigate potential targets for intervention beyond cholesterol reduction.

Main Methods:

  • Review of clinical trials using angiography or ultrasound to assess atherosclerotic lesions.
  • Analysis of data from interventions including diet, drugs, and surgery.
  • Examination of potential mechanisms contributing to clinical benefits.

Main Results:

  • Lipid lowering interventions slowed or regressed atherosclerotic lesions.
  • Observed clinical benefits often exceeded the modest changes in lesion size.
  • Potential mechanisms include lesion stabilization, improved endothelial function, and reduced inflammation.

Conclusions:

  • Clinical benefits of lipid lowering extend beyond absolute reduction in lesion size.
  • Mechanisms like improved vascular function and reduced inflammation play a key role.
  • Identifying additional risk factors such as lipoprotein oxidation, triglycerides, and insulin resistance offers new intervention targets.

Related Experiment Videos